Here’s What Key Metrics Tell Us About Blueprint Medicines (BPMC) Q4 Earnings
Blueprint Medicines (BPMC) reported $71.96 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 85.6%. EPS of -$1.82 for the same period compares to -$2.65…